SCHEMBL6505750

SCHEMBL6505750

O=C(S)C(Br)C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA3 P07451 1/20 0.38
CA4 P22748 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA13 Q8N1Q1 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
PTPN1 P18031 1/20 0.38
CYP2D6 P10635 1/20 0.37
MAPT P10636 2/20 0.36
KMT2A Q03164 1/20 0.36
KCNN4 O15554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3187683 0.75 CYP1A2 (0.46) CYP1A2CES1CA12CA1CA2
SCHEMBL856139 0.74 CYP1A2 (0.41) CYP1A2CYP2D6MAPTKMT2AKCNN4
SCHEMBL342180 0.74 CYP1A2 (0.41) CYP1A2CYP2D6MAPTKMT2AKCNN4
SCHEMBL3185210 0.71 CYP2C19 (0.40) CYP1A2CYP2D6MAPTKMT2AKCNN4
SCHEMBL27713868 0.67 LMNA (0.44) CYP1A2CYP2D6MAPTKMT2AKCNN4
SCHEMBL5665182 0.67 CES2 (0.67) CYP1A2CES2CES1CA12CA1
SCHEMBL28130399 0.67 MAPT (0.41) CYP1A2CYP2D6MAPTKMT2AKCNN4
SCHEMBL1235122 0.67 KMT2A (0.48) CYP1A2CES1CYP2D6MAPTKMT2A
SCHEMBL11779390 0.67 MAPT (0.45) CYP1A2CES2CES1CYP2D6MAPT
SCHEMBL3889406 0.66 KCNN4 (0.52) CYP1A2CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953788-B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase AVENTIS PHARMACEUTICALS INC. (US) 2005-10-11 US disclosed
US-6770640-B1 EMPHYSEMA AVENTIS PHARMACEUTICALS INC. 2004-08-03 US disclosed
EP-0928291-B1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE AVENTIS PHARMA INC (US) 2002-12-04 EP disclosed
EP-1150975-A1 1-CARBOXYMETHYL-2-OXO-AZEPAN DERIVATIVES USEFUL AS SELECTIVE INHIBITORS OF MMP-12 Aventis Pharmaceuticals Inc. (US) 2001-11-07 EP disclosed
WO-2000040577-A1 1-CARBOXYMETHYL-2-OXO-AZEPAN DERIVATIVES USEFUL AS SELECTIVE INHIBITORS OF MMP-12 AVENTIS PHARMACEUTICALS INC. (US) 2000-07-13 WO disclosed
EP-0928291-A1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE HOECHST MARION ROUSSEL, INC. (US) 1999-07-14 EP disclosed
WO-1998012211-A1 3-MERCAPTOACETYLAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN DERIVATIVES USEFUL AS INHIBITORS OF MATRIX METALLOPROTEINASE HOECHST MARION ROUSSEL, INC. (US) 1998-03-26 WO disclosed